{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:13:09Z","timestamp":1793113989654,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Project of Shanghai Municipal Health Commission","award":["202340061"],"award-info":[{"award-number":["202340061"]}]},{"name":"the Special Cultivation Project of Basic Medical Research of the First Affiliated Hospital of Naval Medical University","award":["2023PY40"],"award-info":[{"award-number":["2023PY40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10067-024-07276-w","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:21:28Z","timestamp":1736029288000},"page":"757-766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical characteristics of IgG4-related retroperitoneal fibrosis in a cohort of 117 patients with idiopathic retroperitoneal fibrosis: a retrospective study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-8802","authenticated-orcid":false,"given":"Jia-Qi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6477-3066","authenticated-orcid":false,"given":"Zheng-Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9048-9117","authenticated-orcid":false,"given":"Yi-Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6739-3600","authenticated-orcid":false,"given":"Du-Mu","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-8457","authenticated-orcid":false,"given":"Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1075-3631","authenticated-orcid":false,"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"9506","key":"7276_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. The Lancet 367(9506):241\u2013251","journal-title":"The Lancet"},{"issue":"6","key":"7276_CR2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2214\/ajr.165.6.7484591","volume":"165","author":"L Arrive","year":"1995","unstructured":"Arrive L, Correas JM, Leseche G et al (1995) Inflammatory aneurysms of the abdominal aorta: CT findings. AJR Am J Roentgenol 165(6):1481\u20131484","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"7276_CR3","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/ard.2004.029793","volume":"64","author":"K Warnatz","year":"2005","unstructured":"Warnatz K, Keskin AG, Uhl M et al (2005) Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 64(6):828\u2013833","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7276_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","volume":"92","author":"A Khosroshahi","year":"2013","unstructured":"Khosroshahi A, Carruthers MN, Stone JH et al (2013) Rethinking Ormond\u2019s disease:\u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease. Medicine 92(2):82\u201391","journal-title":"Medicine"},{"issue":"7","key":"7276_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","volume":"5","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Greco P, Corradi D et al (2006) Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5(7):458\u2013464","journal-title":"Autoimmun Rev"},{"issue":"2","key":"7276_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/keaa411","volume":"60","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhu L, Wang Z et al (2021) Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology 60(2):767\u2013772","journal-title":"Rheumatology"},{"issue":"4","key":"7276_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EFH Van Bommel","year":"2009","unstructured":"Van Bommel EFH, Jansen I, Hendriksz TR et al (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine 88(4):193\u2013201","journal-title":"Medicine"},{"issue":"9976","key":"7276_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S et al (2015) IgG4-related disease. The Lancet 385(9976):1460\u20131471","journal-title":"The Lancet"},{"issue":"6","key":"7276_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366(6):539\u2013551","journal-title":"N Engl J Med"},{"issue":"1","key":"7276_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1\u201314","journal-title":"Mod Rheumatol"},{"issue":"8","key":"7276_CR11","first-page":"e17587","volume":"13","author":"M Ouchani","year":"2021","unstructured":"Ouchani M, Bachir H, Hamaz S et al (2021) Retroperitoneal fibrosis: beware of lymphoma. Cureus 13(8):e17587","journal-title":"Cureus"},{"issue":"10","key":"7276_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732\u2013738","journal-title":"N Engl J Med"},{"issue":"Supplement_3","key":"7276_CR13","doi-asserted-by":"publisher","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","volume":"59","author":"F Maritati","year":"2020","unstructured":"Maritati F, Peyronel F, Vaglio A (2020) IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 59(Supplement_3):iii123\u2013iii131","journal-title":"Rheumatology(Oxford)"},{"issue":"8","key":"7276_CR14","first-page":"1031","volume":"18","author":"A Chaba","year":"2023","unstructured":"Chaba A, Devresse A, Audard V et al (2023) Clinical and prognostic factors in patients with IgG4-related kidney disease. Clin J Am Soc Nephrol 18(8):1031\u20131040","journal-title":"Clin J Am Soc Nephrol"},{"key":"7276_CR15","doi-asserted-by":"publisher","first-page":"816830","DOI":"10.3389\/fimmu.2022.816830","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Jin X, Guan L et al (2022) IgG4-related disease with gastrointestinal involvement: case reports and literature review. Front Immunol 13:816830","journal-title":"Front Immunol"},{"issue":"3","key":"7276_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-021-00529-y","volume":"19","author":"JM L\u00f6hr","year":"2022","unstructured":"L\u00f6hr JM, Vujasinovic M, Rosendahl J et al (2022) IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol 19(3):185\u2013197","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"7276_CR17","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s10067-021-05635-5","volume":"40","author":"AM Demir","year":"2021","unstructured":"Demir AM, Aydin F, Acar B et al (2021) IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review. Clin Rheumatol 40(9):3817\u20133825","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7276_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(17)30471-4","volume":"17","author":"MA AbdelRazek","year":"2018","unstructured":"AbdelRazek MA, Venna N, Stone JH (2018) IgG4-related disease of the central and peripheral nervous systems. The Lancet Neurology 17(2):183\u2013192","journal-title":"The Lancet Neurology"},{"issue":"1","key":"7276_CR19","doi-asserted-by":"publisher","first-page":"e003026","DOI":"10.1136\/rmdopen-2023-003026","volume":"9","author":"M Kanda","year":"2023","unstructured":"Kanda M, Kamekura R, Sugawara M et al (2023) IgG4-related disease administered dupilumab: case series and review of the literature. RMD Open 9(1):e003026","journal-title":"RMD Open"},{"key":"7276_CR20","doi-asserted-by":"publisher","first-page":"717902","DOI":"10.3389\/fimmu.2021.717902","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Zhuo N, Luo X et al (2021) IgG4-related disease with testicular involvement: a case report and review of literature. Front Immunol 12:717902","journal-title":"Front Immunol"},{"key":"7276_CR21","doi-asserted-by":"publisher","first-page":"109560","DOI":"10.1016\/j.ejrad.2021.109560","volume":"136","author":"AD Dragan","year":"2021","unstructured":"Dragan AD, Weller A, Lingam RK (2021) Imaging of IgG4-related disease in the extracranial head and neck. Eur J Radiol 136:109560","journal-title":"Eur J Radiol"},{"key":"7276_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00296-020-04555-y","volume":"40","author":"S Okamoto","year":"2020","unstructured":"Okamoto S, Tsuboi H, Sato R et al (2020) IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review. Rheumatol Int 40:1725\u20131732","journal-title":"Rheumatol Int"},{"issue":"12","key":"7276_CR23","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","volume":"34","author":"Y Zen","year":"2010","unstructured":"Zen Y, Nakanuma Y (2010) IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 34(12):1812\u20131819","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"7276_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JKC et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181\u20131192","journal-title":"Mod Pathol"},{"issue":"3","key":"7276_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","volume":"31","author":"H Umehara","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31(3):529\u2013533","journal-title":"Mod Rheumatol"},{"issue":"13","key":"7276_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4103\/0366-6999.184459","volume":"129","author":"Y Chen","year":"2016","unstructured":"Chen Y, Zhao JZ, Feng RE et al (2016) Types of organ involvement in patients with immunoglobulin G4-related disease. Chin Med J 129(13):1525\u20131532","journal-title":"Chin Med J"},{"issue":"11","key":"7276_CR27","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H et al (2015) Clinical characteristics of immunoglobulin G4\u2013related disease: a prospective study of 118 Chinese patients. Rheumatology 54(11):1982\u20131990","journal-title":"Rheumatology"},{"issue":"5","key":"7276_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/key397","volume":"58","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang P, Zhang X et al (2019) Sex disparities in clinical characteristics and prognosis of immunoglobulin G4\u2013related disease: a prospective study of 403 patients. Rheumatology 58(5):820\u2013830","journal-title":"Rheumatology"},{"key":"7276_CR29","doi-asserted-by":"publisher","first-page":"652985","DOI":"10.3389\/fimmu.2021.652985","volume":"12","author":"P Qing","year":"2021","unstructured":"Qing P, Lu C, Liu Z et al (2021) IgG4-related disease with tuberculosis: a case report and retrospective review of patients in a single center. Front Immunol 12:652985","journal-title":"Front Immunol"},{"issue":"1","key":"7276_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.23876\/j.krcp.18.0052","volume":"38","author":"YK Choi","year":"2019","unstructured":"Choi YK, Yang JH, Ahn SY et al (2019) Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease. Kidney Res Clin Pract 38(1):42","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"7276_CR31","first-page":"297","volume":"86","author":"TA Kermani","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ et al (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes[C]\/\/Mayo Clinic Proceedings. Elsevier 86(4):297\u2013303","journal-title":"Elsevier"},{"issue":"2","key":"7276_CR32","doi-asserted-by":"publisher","first-page":"e0245601","DOI":"10.1371\/journal.pone.0245601","volume":"16","author":"K Wang","year":"2021","unstructured":"Wang K, Wang Z, Zeng Q et al (2021) Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS ONE 16(2):e0245601","journal-title":"PLoS ONE"},{"key":"7276_CR33","unstructured":"Carruthers M, Augustin T, Stone J H, et al (2012) Diagnostic utility of serum IgG4 in IgG4-related disease[C]\/\/Arthritis And Rheumatism. 111 River St, Hoboken 07030\u20135774, NJ USA: Wiley-Blackwell 64(10):S815-S816"},{"key":"7276_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6936727","volume":"2018","author":"I Puxeddu","year":"2018","unstructured":"Puxeddu I, Capecchi R, Carta F et al (2018) Salivary gland pathology in IgG4-related disease: a comprehensive review. J Immunol Res 2018:1","journal-title":"J Immunol Res"},{"issue":"2","key":"7276_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/14397595.2014.931908","volume":"25","author":"BS Koo","year":"2015","unstructured":"Koo BS, Koh YW, Hong S et al (2015) Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol 25(2):194\u2013198","journal-title":"Mod Rheumatol"},{"issue":"5","key":"7276_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/PAS.0b013e318157c068","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HKL, Chu SYY et al (2008) Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 32(5):671\u2013681","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"7276_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4103\/1319-2442.160226","volume":"26","author":"J Labidi","year":"2015","unstructured":"Labidi J, Ariba YB, Chargui S et al (2015) Retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment and outcomes. Saudi J Kidney Dis Trans 26(4):816\u2013822","journal-title":"Saudi J Kidney Dis Trans"},{"issue":"6","key":"7276_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","volume":"71","author":"A Fernando","year":"2017","unstructured":"Fernando A, Pattison J, Horsfield C et al (2017) 18F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study[J. Eur Urol 71(6):926\u2013933","journal-title":"Eur Urol"},{"key":"7276_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.eururo.2017.09.024","volume":"73","author":"E AccorsiButtini","year":"2018","unstructured":"AccorsiButtini E, Maritati F, Vaglio A (2018) 18F]-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis[J. Eur Urol 73:145\u2013146","journal-title":"Eur Urol"},{"issue":"9","key":"7276_CR40","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/art.40168","volume":"69","author":"CA Perugino","year":"2017","unstructured":"Perugino CA, Mattoo H, Mahajan VS et al (2017) Emerging treatment models in rheumatology: IgG4-related disease: insights into human immunology and targeted therapies. Arthritis Rheumatol 69(9):1722\u20131732","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"7276_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T et al (2016) Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol 138(3):825\u2013838","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"7276_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","volume":"57","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Suzuki K, Yasuoka H et al (2018) Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology 57(2):236\u2013245","journal-title":"Rheumatology"},{"issue":"5","key":"7276_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","volume":"49","author":"EFH van Bommel","year":"2007","unstructured":"van Bommel EFH, Siemes C, Hak LE et al (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49(5):615\u2013625","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"7276_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2011-200148","volume":"71","author":"M Binder","year":"2012","unstructured":"Binder M, Uhl M, Wiech T et al (2012) Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis 71(2):311\u2013312","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7276_CR45","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L et al (2013) Brief report: Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 65(9):2469\u20132475","journal-title":"Arthritis Rheum"},{"issue":"3","key":"7276_CR46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/annrheumdis-2019-216258","volume":"79","author":"ML Urban","year":"2020","unstructured":"Urban ML, Maritati F, Palmisano A et al (2020) Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients. Ann Rheum Dis 79(3):433\u2013434","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7276_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","volume":"39","author":"PJ Scheel","year":"2013","unstructured":"Scheel PJ, Feeley N (2013) Retroperitoneal fibrosis. Rheum Dis Clin 39(2):365\u2013381","journal-title":"Rheum Dis Clin"},{"key":"7276_CR48","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S2665-9913(23)00299-0","volume":"6","author":"M Lanzillotta","year":"2024","unstructured":"Lanzillotta M, Culver E, Sharma A et al (2024) Fibrotic phenotype of IgG4-related disease. Lancet Rheumatol 6:e469","journal-title":"Lancet Rheumatol"},{"key":"7276_CR49","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/S2665-9913(24)00022-5","volume":"6","author":"G Katz","year":"2024","unstructured":"Katz G, Hernandez-Barco Y, Palumbo D et al (2024) Proliferative features of IgG4-related disease. Lancet Rheumatol 6:e481","journal-title":"Lancet Rheumatol"},{"key":"7276_CR50","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00261-017-1282-5","volume":"43","author":"RH Cohan","year":"2018","unstructured":"Cohan RH, Shampain KL, Francis IR et al (2018) Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made? Abdom Radiol 43:1204\u20131214","journal-title":"Abdom Radiol"},{"key":"7276_CR51","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","volume":"39","author":"G Moroni","year":"2012","unstructured":"Moroni G, Castellani M, Balzani A et al (2012) The value of 18 F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging 39:1635\u20131642","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07276-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:38:23Z","timestamp":1738049903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07276-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7276"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07276-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All participants were properly consented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}